Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2 : Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions

Elens, Laure;Langman, Loralie J.;Hesselink, Dennis A.;Bergan, Stein;Lemaitre, Florian;et.al.
(2020) Therapeutic Drug Monitoring — Vol. 42, n° 3, p. 360-368 (2020)

Files

tdm-publish-ahead-of-print-101097ftd0000000000000761.pdf
  • Open Access
  • Adobe PDF
  • 151.93 KB
Download

Details

Authors
  • Elens, LaureUCLouvain
    Author
  • Langman, Loralie J.
    Author
  • Hesselink, Dennis A.
    Author
  • Bergan, Stein
    Author
  • Lemaitre, Florian
    Author
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Elens, L., Langman, L. J., Hesselink, D. A., Bergan, S., Moes, D. J. A. R., Molinaro, M., Venkataramanan, R., & Lemaitre, F. (2020). Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2 : Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions. Therapeutic Drug Monitoring, 42(3), 360-368. https://doi.org/10.1097/ftd.0000000000000761 (Original work published 2020)